Cargando…

Zinc for infection prevention in children with sickle cell anemia: a randomized double-blind placebo-controlled trial

Data from small clinical trials in the United States and India suggest zinc supplementation reduces infection in adolescents and adults with sickle cell anemia (SCA), but no studies of zinc supplementation for infection prevention have been conducted in children with SCA living in Africa. We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Namazzi, Ruth, Opoka, Robert, Conroy, Andrea L., Datta, Dibyadyuti, Tagoola, Abner, Bond, Caitlin, Goings, Michael J., Ryu, Moon-Suhn, Cusick, Sarah E., Krebs, Nancy F., Jang, Jeong Hoon, Tu, Wanzhu, Ware, Russell E., John, Chandy C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Clinical Trials and Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331409/ https://www.ncbi.nlm.nih.gov/pubmed/36735400 http://dx.doi.org/10.1182/bloodadvances.2022008539

Ejemplares similares

Decreased parasite burden and altered host response in children with sickle cell anemia and severe anemia with malaria
por: Henrici, Ryan C., et al.
Publicado: (2021)

Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS): study protocol for a randomized placebo-controlled trial in Ugandan children with sickle cell anemia
por: Datta, Dibyadyuti, et al.
Publicado: (2019)

Impact of a National Lockdown for COVID-19 on Morbidity and Mortality Among Children with Sickle Cell Anaemia at a Tertiary Care Hospital in Uganda
por: Namazzi, Ruth, et al.
Publicado: (2020)

PI-08: HIGH DISEASE BURDEN, MORBIDITY AND MORTALITY AMONG CHILDREN WITH SICKLE CELL ANAEMIA IN UGANDA
por: R., NAMAZZI, et al.
Publicado: (2022)

Intestinal Injury Biomarkers Predict Mortality in Pediatric Severe Malaria
por: Sarangam, Maithri L., et al.
Publicado: (2022)

Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysis
por: Ataga, Kenneth I., et al.
Publicado: (2022)

Association of Plasma Tau With Mortality and Long-term Neurocognitive Impairment in Survivors of Pediatric Cerebral Malaria and Severe Malarial Anemia
por: Datta, Dibyadyuti, et al.
Publicado: (2021)

Xanthine oxidase levels and immune dysregulation are independently associated with anemia in Plasmodium falciparum malaria
por: Vasquez, Marilyn, et al.
Publicado: (2023)

Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy
por: Dhar, Arushi, et al.
Publicado: (2021)

Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

Acute kidney injury, persistent kidney disease, and post-discharge morbidity and mortality in severe malaria in children: A prospective cohort study
por: Namazzi, Ruth, et al.
Publicado: (2022)

High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya
por: McAuley, Charlotte F., et al.
Publicado: (2010)

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
por: Elalfy, Mohsen S., et al.
Publicado: (2022)

Renin as a Biomarker of Acute Kidney Injury and Mortality in Children With Severe Malaria or Sickle Cell Disease
por: Adan Jr., Daniel, et al.
Publicado: (2023)

Elevated Plasma Soluble ST2 Levels are Associated With Neuronal Injury and Neurocognitive Impairment in Children With Cerebral Malaria
por: Fernander, Elizabeth M., et al.
Publicado: (2022)

P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
por: POWER-HAYS, A., et al.
Publicado: (2022)

Identifying Risk Factors That Distinguish Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection From Common Upper Respiratory Infections in Children
por: Schneider, Jack G, et al.
Publicado: (2021)

Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines
por: Adamkiewicz, Thomas V., et al.
Publicado: (2023)

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2022)

Acute kidney injury in hospitalized children with sickle cell anemia
por: Batte, Anthony, et al.
Publicado: (2022)

Metformin for treatment of cytopenias in children and young adults with Fanconi anemia
por: Pollard, Jessica A., et al.
Publicado: (2022)

Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection
por: Minniti, Caterina P., et al.
Publicado: (2021)

What causes severe malaria and its complications in children? Lessons learned over the past 15 years
por: Conroy, Andrea L., et al.
Publicado: (2019)

Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease
por: Mucalo, Lana, et al.
Publicado: (2021)

Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries
por: Jiao, Boshen, et al.
Publicado: (2023)

Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study
por: Heeney, Matthew M., et al.
Publicado: (2022)

Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests
por: Olaniyan, Halimat S., et al.
Publicado: (2023)

Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis
por: Oh, Stephen T., et al.
Publicado: (2023)

C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia
por: de Boer, Esther C. W., et al.
Publicado: (2023)

Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study
por: Kwiatkowski, Janet L., et al.
Publicado: (2022)

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study
por: Quinn, Charles T., et al.
Publicado: (2022)

Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens
por: Teigen, David, et al.
Publicado: (2023)

Parenteral artemisinins are associated with reduced mortality and neurologic deficits and improved long-term behavioral outcomes in children with severe malaria
por: Conroy, Andrea L., et al.
Publicado: (2021)

Acute kidney injury is associated with impaired cognition and chronic kidney disease in a prospective cohort of children with severe malaria
por: Conroy, Andrea L., et al.
Publicado: (2019)

Autoantibody levels are associated with acute kidney injury, anemia and post-discharge morbidity and mortality in Ugandan children with severe malaria
por: Rivera-Correa, Juan, et al.
Publicado: (2019)

Is Sickle Cell Anemia a Neglected Tropical Disease?
por: Ware, Russell E.
Publicado: (2013)

Plasma angiopoietin-2 is associated with age-related deficits in cognitive sub-scales in Ugandan children following severe malaria
por: Ouma, Benson J., et al.
Publicado: (2021)

Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant
por: Solomon, Scott R., et al.
Publicado: (2023)

Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial
por: Woller, Scott C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ipek8237501gojvnojitfbbkvr